Podcast
Podcaster
The Milk Road Show
Du folgst jetzt diesem Podcast.
Beschreibung
vor 1 Jahr
In this episode, we’re joined by Ryan Watkins, founder of
Syncracy Capital, to explore one of the most interesting
developments in the crypto ecosystem: Hyperliquid. Ryan shares
his in-depth investment thesis on why Hyperliquid, a fast-growing
onchain exchange and emerging Layer 1, may have the potential to
challenge the dominance of Solana and Ethereum.
~~~~~
Get no trading fees for your first $25K in trading volume
on Definitive:
https://out.milkroad.com/Definitive2025Podcast
Borrow against your Bitcoin with Ledn, fast, secure, and without
selling a sat:
https://out.milkroad.com/Ledn2025Podcast
~~~~~
Get smarter about crypto with our daily newsletter:
https://milkroad.com/subscribe/join-mr/?utm_medium=audio&utm_source=podcast_organic&utm_campaign=sign-up-free&utm_content=july_24_25
Go PRO and become a better investor with the #1 crypto research
and analysis:
https://milkroad.com/offer/sign-up-for-pro/?utm_medium=audio&utm_source=podcast_organic&utm_campaign=sign-up-pro&utm_content=july_24_25
Get your pain-free crypto portfolio GUIDE for 2025:
https://milkroad.com/subscribe/get-the-guide/?utm_medium=audio&utm_source=podcast
~~~~~
Follow Milk Road on Social Media:
Milk Road
Twitter:https://link.milkroad.com/X
Milk Road
Instagram:https://link.milkroad.com/pod-ig
Apple
Podcasts:https://link.milkroad.com/apple-podcast
~~~~~
GUEST INFO
Ryan Watkins: https://x.com/RyanWatkins_
Syncracy Capital: https://www.syncracy.io/
Disclaimer
The information presented in this video is for educational and
informational purposes only. It should not be considered as
financial, legal. The views and opinions expressed by the
speakers, are their own and do not constitute professional
advice. Investing in cryptocurrencies carries significant risks,
including the potential for substantial losses.
Weitere Episoden
34 Minuten
vor 7 Monaten
33 Minuten
vor 7 Monaten
33 Minuten
vor 7 Monaten
35 Minuten
vor 7 Monaten
49 Minuten
vor 7 Monaten
Kommentare (0)
Melde Dich an, um einen Kommentar zu schreiben.